Mihaela Andreea Podeanu

Dr. Mihaela Andreea Podeanu

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
Mihaela Andreea PodeanuMihaela Andreea Podeanu
Mihaela Andreea Podeanu
Adina Turcu-StiolicaAdina Turcu-Stiolica
Adina Turcu-Stiolica
MNMihaela-Simona Naidin
Mihaela-Simona Naidin
MIOARA DESDEMONA STEPANMIOARA DESDEMONA STEPAN
MIOARA DESDEMONA STEPAN
Claudiu Marinel IoneleClaudiu Marinel Ionele
Claudiu Marinel Ionele
RSRaluca Elena Sandu
Raluca Elena Sandu
Metabolic syndrome (MetS) in the pediatric population has been reported in many studies to be associated with an inflammatory response. However, to our knowledge, there is no definitive conclusion in the form of a meta-analysis. The issue we aimed to address is whether C-reactive protein (CRP) is a trustworthy marker in detecting inflammation in children and adolescents with MetS. We systematically searched PubMed, MEDLINE, Cochrane Central Register of Controlled Trials, the ISI Web of Science, and SCOPUS until 31 June 2023 for studies involving children and adolescents with MetS where hsCRP or CRP were measured. After the screening process, we identified 24 full-text articles that compared 930 patients with MetS with either healthy (n = 3782) or obese (n = 1658) controls. The risk of bias in the included studies was assessed using the Begg’s rank correlation test and Egger’s regression test. Statistical analysis was carried out based on pooled mean differences (MDs) and an associated 95% CI. Data analysis showed that MetS is associated with higher levels of CRP than those in healthy controls (MD = 1.28, 95% CI: (0.49–2.08), p = 0.002) in obese patients (MD = 0.88, 95% CI: (0.38–1.39), p = 0.0006). However, conventional methods of CRP analysis were found to be more accurate in differentiating between children and adolescents with obesity and those with MetS, compared with hsCRP (MD = 0.60, 95% CI: (−0.08–1.28), p = 0.08). No risk of bias was assessed. In conclusion, CRP is a reliable inflammatory marker for differentiating pediatric patients with MetS from healthy ones. On the other hand, it did not prove to be very accurate in distinguishing between patients who had MetS and those who were obese. There should be more research performed in this field.

27 April 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
MIOARA DESDEMONA STEPANMIOARA DESDEMONA STEPAN
MIOARA DESDEMONA STEPAN
SVStefanita Bianca vintilescu
Stefanita Bianca vintilescu
ISIOANA STREATA
IOANA STREATA
Mihaela Andreea PodeanuMihaela Andreea Podeanu
Mihaela Andreea Podeanu
DFDan Nicolae Florescu
Dan Nicolae Florescu
Non-alcoholic fatty liver disease (NAFLD) represents a complex chronic condition, which in the absence of screening–monitoring markers and effective standardized treatment is one of the most important issues in pediatric pathology. In this study, we analyzed the role of vitamin D supplementation in obese children with/without NAFLD and the impact on the components of the associated metabolic syndrome (MS). The study included 22 children with simple obesity (SO) and 50 with NAFLD, aged between 6 and 14 years, who received regimen-based therapy or vitamin D supplementation in case of deficiency. Anthropometric and paraclinical data associated with MS were statistically compared before and after treatment. It was observed that there was a statistical association of NAFLD with MS components, which were present both in SO and in the 6–9 years group. Vitamin D deficiency was associated with the presence of obesity, NAFLD and MS components, and correction of the deficiency induced a tendency to normalize the associated parameters. In the case of a treatment strictly based on the regimen, we found decreases in vitamin D values and additional alteration of some parameters. Supplementation with vitamin D potentiates the effects of the specific regimen, and the effects seem to be dependent on the MS components.

23 September 2024 in Life
Verified
Journal Article
Open access
PDF file
Mihaela Andreea PodeanuMihaela Andreea Podeanu
Mihaela Andreea Podeanu
SVStefanita Bianca vintilescu
Stefanita Bianca vintilescu
Claudiu Marinel IoneleClaudiu Marinel Ionele
Claudiu Marinel Ionele
RSRaluca Elena Sandu
Raluca Elena Sandu
CNCarmen Elena Niculescu
Carmen Elena Niculescu
MIOARA DESDEMONA STEPANMIOARA DESDEMONA STEPAN
MIOARA DESDEMONA STEPAN
Obesity is linked to the increasing prevalence of metabolic syndrome (MetS), even among the pediatric population. Some inflammatory and cardioembolic indexes derived from routine laboratory tests have captivated the attention of the medical community. Objectives: The aim of our study was to evaluate whether these markers are effective in distinguishing varying degrees of obesity and MetS in children and adolescents. Methods: We conducted a retrospective study. A total of 71 children and adolescents, aged between 6 and 16, were included in the study. Among them, 5 were overweight, 35 had obesity, and 31 had severe obesity. According to the NCEP ATP III criteria, 32 individuals had Metabolic Syndrome (MetS), while 39 did not have MetS. Results: The MetS positive group had higher values of TG/HDL-C (p < 0.001), TC/HDL-C (p < 0.001), MHR (p = 0.015), LHR (p = 0.001), NHR (p = 0.001), atherogenic index of plasma (p < 0.001), and PHR (p < 0.001). ESR, NLR, PLR, and SII did not progressively increase with the number of MetS criteria. The ROC curve analysis demonstrated that markers such as TG/HDL-C, the atherogenic index of plasma, TC/HDL-C, LHR, NHR, and PHR were effective in identifying MetS in children and adolescents with obesity. Conclusions: In conclusion, we determined that some novel inflammatory and cardioembolic indexes are useful in assessing MetS and obesity in children and adolescents.

11 February 2026 in Life
Verified
Journal Article
Open access
PDF file
Mihaela Andreea PodeanuMihaela Andreea Podeanu
Mihaela Andreea Podeanu
Claudiu Marinel IoneleClaudiu Marinel Ionele
Claudiu Marinel Ionele
RSRaluca Elena Sandu
Raluca Elena Sandu
IRIon Rogoveanu
Ion Rogoveanu
MIOARA DESDEMONA STEPANMIOARA DESDEMONA STEPAN
MIOARA DESDEMONA STEPAN
SVStefanita Bianca vintilescu
Stefanita Bianca vintilescu
Childhood obesity has emerged as a major global health challenge, with a marked increase in prevalence. Defined by excessive fat accumulation, it is associated with an increased risk of developing metabolic syndrome (MetS) and metabolic dysfunction-associated steatotic liver disease (MASLD). These conditions share common pathophysiological mechanisms, involving chronic low-grade inflammation, adipose tissue dysfunction, and insulin resistance. Excess weight contributes to the development of MetS even in the pediatric population through abdominal fat accumulation, dyslipidemia, hypertension, and hyperglycemia, while also creating a pro-inflammatory state that enhances hepatic fat accumulation, leading to MASLD. It is a bidirectional relationship, with MASLD increasing the risk of hypertension and the development of MetS individual components and as a whole. Adipose tissue, especially visceral fat, acts as a metabolic and immunologic organ, producing pro-inflammatory cytokines, which further accentuate insulin resistance and hepatic injury. The “three-strike” hypothesis illustrates the progression of MASLD. Several inflammatory biomarkers, including C-reactive protein, interleukins, adipokines, and serum ferritin, have been studied to monitor and predict disease progression in pediatrics. However, their diagnostic value in children remains limited due to age-related variability and lack of standardized pediatric cut-off points. A unified definition of pediatric MetS and MASLD is crucial to improve study comparability and clinical applicability. Such standardization would support the development of targeted strategies for early identification and intervention.

Verified
Journal Article
Open access
PDF file
Mihaela Andreea PodeanuMihaela Andreea Podeanu
Mihaela Andreea Podeanu
SVStefanita Bianca vintilescu
Stefanita Bianca vintilescu
RSRaluca Elena Sandu
Raluca Elena Sandu
Claudiu Marinel IoneleClaudiu Marinel Ionele
Claudiu Marinel Ionele
CNCarmen Elena Niculescu
Carmen Elena Niculescu
MIOARA DESDEMONA STEPANMIOARA DESDEMONA STEPAN
MIOARA DESDEMONA STEPAN
This study analyzed the relationship between obesity, metabolic syndrome (MetS) and its individual components, iron metabolism, and hepatic alterations in a pediatric group of patients. We mostly concentrated on the role of serum ferritin as a marker of inflammation. We conducted a retrospective study, in which we determined the presence of MetS and hepatic ultrasound changes in a cohort of 68 pediatric patients and examined the changes in serum iron and ferritin levels. MetS prevalence was significantly higher in obese children (64%) compared to those with average weight (11.1%). Abdominal circumference, triglycerides, and high-density lipoprotein cholesterol were the most relevant MetS criteria. Serum iron levels were significantly lower, while ferritin levels increased proportionally with MetS number of components. Liver ultrasound findings confirmed a strong association between hepatic steatosis and MetS, with advanced ultrasonographic scores correlating with increased ferritin and serum iron deficiency. These results reinforce the interplay between iron metabolism and inflammation in pediatric MetS. Given this study’s unicentric design and limited ethnic diversity, further large-scale, longitudinal studies are needed to confirm these findings and improve early screening strategies for pediatric metabolic complications.

7 April 2024 in Life
Verified
Journal Article
Open access
PDF file
MIOARA DESDEMONA STEPANMIOARA DESDEMONA STEPAN
MIOARA DESDEMONA STEPAN
SVStefanita Bianca vintilescu
Stefanita Bianca vintilescu
Claudiu Marinel IoneleClaudiu Marinel Ionele
Claudiu Marinel Ionele
GDGheorghe Gindrovel Dumitra
Gheorghe Gindrovel Dumitra
Mihaela Andreea PodeanuMihaela Andreea Podeanu
Mihaela Andreea Podeanu
DFDan Nicolae Florescu
Dan Nicolae Florescu
The nutritional status of children is always a concern for medical professionals. Increasingly, obesogenic factors have created a new global epidemic. Obesity is characterized by persistent inflammation, which can have detrimental effects on the growth and development of children. Iron and ferritin are both important factors to consider when evaluating these children due to their role in the pathophysiology of chronic inflammation. Recently, ultrasonographic evaluation seems to be an increasingly used method in pediatric clinical practice. In this study, we included 98 children aged 6–14 years, 72 of whom were obese and 26 had normal weight. The data obtained indicated that there was an association between low iron and increased ferritin levels, aspects of non-alcoholic fatty liver visualized by ultrasonography, and the degree of fibrosis assessed elastographically. Ultrasonography can help us identify liver damage, but the possibility of identifying an association with other paraclinical investigations such as iron and ferritin levels can be cumulative. In this way, the assessment can be more complex, as the child benefits from comprehensive evaluation and management. The results drew attention to non-invasive, easy-to-perform, and low-cost methods of assessing obese children in terms of iron metabolism and structural liver changes.